Your provider will screen for all of these at consultation
According to our statistical analysis, a total of 27 organ systems were affected by tirzepatide-related ADEs
A proportion of participants in the retatrutide trial discontinued treatment due to gastrointestinal side effects that did not resolve
Food and Drug Administration (FDA) doesn't regulate these injections as strictly as prescription medications
Clinical manifestations range from asymptomatic elevations in serum transaminases to more severe conditions, including cholestatic jaundice, peliosis hepatis, hepatic adenomas, and, in rare cases, hepatocellular carcinoma (75)
During this visit, your physician reviews: Health history , including prior medical conditions and medications Weight trends over time , not just your current number on the scale Metabolic risk factors such as insulin resistance, blood sugar patterns, or hormonal changes Personal goals , including energy, metabolic health, and long-term sustainability This step ensures that tirzepatide is an appropriate option and helps set realistic expectations around timelines and outcomes